Tracking migraine relief after a minimally invasive artery procedure
Part of Brain & nervous system, Pain clinical trials.
This study follows adults who undergo a procedure called middle meningeal artery embolization—a minimally invasive treatment that blocks blood flow to a specific artery thought to trigger migraines. The trial simply tracks your symptoms and quality of life before and after the procedure to understand how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old
- You have been diagnosed with migraine
- You have already had or plan to have middle meningeal artery embolization (a minimally invasive procedure to treat migraine)
- You can read and understand English well enough to complete surveys and consent forms
- You are able and willing to give informed consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new procedure that uses tiny coils to block a specific artery in the head, which may help reduce migraine attacks. It is for people who have tried at least two different preventive migraine medicines without success.
This study tests a procedure that blocks a specific artery in the lining of the brain to see if it can reduce migraine attacks. If you have frequent migraines that haven't improved with medication, this might be a new option worth discussing with your doctor.
This study tests a procedure called MMA embolization (blocking a small artery in the head) to see if it can reduce migraine attacks in people with chronic, hard-to-treat migraines.
This trial tests a procedure called bilateral middle meningeal artery embolization to see if it reduces chronic migraine symptoms in people who haven't found relief from other treatments. It's for those with frequent, disabling migraines that affect both sides of the head.
This trial tests a procedure that blocks a blood vessel in the head to see if it reduces chronic migraine pain. It might help people who have not found relief from other treatments.
This trial tests a minimally invasive procedure called middle meningeal artery embolization (using tiny particles to block a small artery) to treat chronic subdural hematoma, a condition where blood slowly builds up on the brain's surface. The goal is to help the body reabsorb the blood and prevent the need for repeated surgeries.
Hear when a new Migraine Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.